Report
Rob Hales
EUR 850.00 For Business Accounts Only

Morningstar | SOLB Updated Forecasts and Estimates from 17 Aug 2018

No-moat Solvay reported good results in the second quarter, with EBITDA ahead of our expectations in all segments. Second-quarter underlying EBITDA of EUR 618 million was down 3% on currency headwinds and a tough comparable. However, organic underlying EBITDA growth was up 4% in the quarter and 6% for the first half, which is right in the middle of 2018 guidance for growth of 5%-7%. We don’t expect to make a material change to our forecasts or EUR 95 fair value estimate. At current levels, the shares look overvalued.

In advanced materials, first-half organic underlying EBITDA growth was 5% (negative 3% after currency effects). Growth was driven primarily by specialty polymers for automotive applications and composites for commercial and military aircraft. We expect strong growth in the medium term in specialty polymers, owing to Solvay’s ability to capitalise on the lightweighting trend with its market-leading portfolio of polymer technologies. High growth in composites should continue in the next one to two years as production of the Leap engine and F-35 fighter jet ramps up.

In advanced formulations, first-half organic underlying EBITDA growth was 17% (2% after currency effects). The sharp uptick in organic growth is coming from the oil chemicals business in Novecare, which is heavily exposed to the U.S. shale oil and gas market. Unfortunately, this also results in the largest currency headwind, owing to the depreciating U.S. dollar versus the euro. We expect the current recovery in oil and gas to peter out in 2019 as global oil prices cool with increased production from U.S. shale.

In performance chemicals, first-half organic underlying EBITDA growth was negative 3% (negative 9% after currency effects). Higher energy and freight costs in soda ash continue to drive the negative print, with modest pressure from soda ash prices. Peroxides was the bright spot, with the new plant in China ramping up in tight market conditions. As soda ash is the main driver of this segment, we have modest growth expectations, given that new low-cost soda ash capacity in the market should weigh on prices and margins, particularly in 2019 as annual contracts are renegotiated.
Underlying
Solvay SA

Solvay is engaged in chemical and plastic businesses worldwide. Co. offers chemical products such as advanced materials, barium strontium, calcium chloride, caustic soda, chlorinated products, fluor, peroxygen products, polyglycerols, precipitated calcium carbonate, soda ash, and sodium bicarbonate. It also provides specialty polymers, such as Spire ultra polymers, Solviva biomaterials, and sulfone polymers. Co. structures its activities around five operating segments: Advanced Formulations, Advanced Materials, Performance Chemicals, Functional Polymers and Corporate & Business Services, each with its own specific business model and each comprised of Global Business Units (GBUs).

Provider
Morningstar
Morningstar

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.

Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.

We have operations in 27 countries.

Analysts
Rob Hales

Other Reports on these Companies
Other Reports from Morningstar

ResearchPool Subscriptions

Get the most out of your insights

Get in touch